Get the facts on diseases, conditions, tests and procedures.
Enter the last name, specialty or keyword for your search below.
The structural heart team, from left: Rani Hasan, Jon Resar, Matthew Czarny, Matthews Chacko, Michael Siegenthaler and Stefano Schena.
Originally intended for high-risk patients, TAVR is now being offered to low-risk ones as part of a national clinical trial that includes Johns Hopkins.
Read More
Database Helps Track Rare Congenital Aortic Syndromes
Patients dealing with rare anomalies of the peripheral vascular system can now turn to a database linking patients to physicians to help relieve complications.
Reducing Inflammation After Heart Attacks May Prevent Secondary Events
A treatment normally reserved for patients with stubbornly high low-density lipoprotein (LDL) cholesterol offers promise to reduce inflammation after heart attacks.
Meet five new experts with specialized cardiovascular skills and diverse research interests.
ECMO Team Approach Improves Odds for Critically Ill Patients
Specialists work together to review concerns as the machine allows critically ill patients their best chance to recover function.
Language Assistance Available:
© The Johns Hopkins University, The Johns Hopkins Hospital, and Johns Hopkins Health System. All rights reserved.
